Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.

Autor: Nagase, Yoshikazu1 (AUTHOR), Hiramatsu, Kosuke1 (AUTHOR) hiramatsu@gyne.med.osaka-u.ac.jp, Funauchi, Masashi1,2,3,4 (AUTHOR), Shiomi, Mayu1 (AUTHOR), Masuda, Tatsuo1 (AUTHOR), Kakuda, Mamoru1 (AUTHOR), Nakagawa, Satoshi1 (AUTHOR), Miyoshi, Ai1 (AUTHOR), Matsuzaki, Shinya1,5 (AUTHOR), Kobayashi, Eiji1 (AUTHOR), Kimura, Toshihiro1 (AUTHOR), Serada, Satoshi3,4 (AUTHOR), Ueda, Yutaka1 (AUTHOR), Naka, Tetsuji2,3,4 (AUTHOR), Kimura, Tadashi1 (AUTHOR)
Zdroj: BMC Cancer. 6/21/2022, Vol. 22 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje